Corporate and Advisory Boards
Randy Marfin; Director: CEO Biophysical Corp. Previously, Vice President of Strategic Development, Luminex Corp, responsible for corporate strategic planning; and Vice President of Sales and Marketing for SpectraCell Laboratories, Inc, a blood wellness clinicallaboratory, where he was responsible for business development, acquisitions, strategic planning and sales and marketing.
Michael Spain, MD; Chief Science Advisor: Chief Medical Officer, Rules Based Medicine (Myriad). Previously, Vice President, Clinical Affairs and Chief Medical Officer Luminex Corp. Medical Director of Laboratory Corporation of America; and Medical Director of Quest Laboratory (formerly Damon Clinical Laboratory). Following a four-year residency in pathology at Baylor University Medical Center in Dallas, he became board certified in 1984.
James Oury; Director: Partner, Oury Clark Chartered Accountants, and founder Oury Clark Solicitors. James works closely with many growing biomedical companies, and is a Director on the Boards of Gene Solutions LLC and Aptamer Group. James is a dual-qualified practicing solicitor and Fellow of the Institute of Chartered Accountants in England and Wales and a member of the International Bar Association. Previously Co-founder, General Counsel, and Director of DNA Electronics Limited.
Michael Goldstein, M.D, M.M; Director: Co-director of the cornea service and assistant professor at New England Eye Center/Tufts Medical Center. MBA from the Kellogg. Dr. Goldstein has authored 8 textbook chapters and has over 30 peer-reviewed publications. Currently serves as President of the Massachusetts Society of Eye Physician and Surgeons and President of CLAO. Dr. Goldstein also consults to the biotechnology sector in the development of new drugs and devices.
Peter Los; Director: Managing Director, Anavatos Partners and Mount Royal Ventures. Peter has over ten years experience investing in and working with emerging companies, including at American Aerogel where he lead business development activities. Previous experience includes specialty commercial lending and construction management. He serves on the Boards of American Aerogel and the Rochester Angel Network.
David Arslanian; Director: Vice President of Integration Strategy for Pointroll; previously President and COO of Rovion, and co-founder, Inanovate, Inc. Senior corporate strategist and deal architect with a proven record of founding and funding early stage technology companies, and identifying and negotiating private mergers. MBA Babson College.
Brian Warrington, PhD; Advisor: Director BB Consulting. Previously Vice President of Technology Development for GlaxoSmithKline; Chairman of the INSIGHT High Throughput Technologies Faraday Partnership; Member of DTI National Strategic Advisory Group on Micro & Nanotechnology.
Glen Wegner, J.D, M.D; Advisor: 35 yrs experience in business, medicine, law, investment banking and public service. As an entrepreneurial founder and leader, Glen has been involved in all aspects of business from concept through IPO and SEC regulated public companies.